+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Allergic Asthma Therapeutics Market - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

  • ID: 5327728
  • Report
  • July 2020
  • Region: Global
  • Coherent Market Insights Pvt Ltd.

FEATURED COMPANIES

  • Axikin Pharmaceuticals
  • Chiesi Farmaceutici SpA
  • Fountain Biopharma Inc.
  • Hydra Biosciences
  • Kineta
  • Mycenax Biotech Inc.
Asthma is a long-term inflammatory lung disease which is caused by inflammation and narrowing in the air passage resulting from environmental and genetic influences. Allergic asthma is one of the most common types of asthma. Allergic asthma is triggered by inhaling allergens such as mold, pollen, pet dander, and dust mite allergen resulting in symptoms of allergic asthma which include chest tightness, rapid breathing or shortness of breath, wheezing, and coughing.

Market Dynamics

The rising incidence of respiratory diseases and the growing demand for cost-effective treatments are expected to propel the allergic asthma therapeutics market growth in future. Additionally, an increase in pollution levels and an upsurge in cases of chronic obstructive pulmonary diseases (COPD) are other factors boosting the market growth. According to the World Health Organization (WHO), more than 200 million people suffer from COPD and around 235 million have asthma all across the globe.

Allergic asthma therapeutics are cost-effective and gaining popularity among patients and healthcare professionals due to launches of novel drugs by key players. This is estimated to drive the market growth during the forecast period.

Moreover, governments are taking initiatives to provide better care and treatment for patients, and are focusing on increasing awareness about allergic asthma which is contributing to the allergic asthma therapeutics market growth. However, the increasing use of generic drugs and upsurge in patent expiry of drugs are predicted to restrict the market growth in the forecast period.

Key features of the study:
  • This report provides in-depth analysis of the global allergic asthma therapeutics market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2020-2027, considering 2019 as the base year
  • It elucidates potential revenue opportunity across different segments and explains an attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles key players in the global allergic asthma therapeutics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and strategies
  • Key players covered as a part of this study are Aslan Pharmaceuticals Pte. Ltd., Baxalta Incorporated, Axikin Pharmaceuticals, Chiesi Farmaceutici SpA, CSL Limited, Circassia Pharmaceuticals Plc, Fountain Biopharma Inc., Hydra Biosciences, GlaxoSmithKline Plc, Infinity Pharmaceuticals, Mabtech Limited, Kineta, Marinomed Biotechnologie Gmb, NeoPharm Co., Mycenax Biotech Inc., Panacea Biotec Limited, and Oxagen Limited.
  • Insights from this report would allow marketers and management authorities of companies to make an informed decision with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global allergic asthma therapeutics market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for allergic asthma therapeutics market, research and consulting firms, new entrants, and financial analysts.
Detailed Segmentation:

Global Allergic Asthma Therapeutics Market, By Drug Type:
  • Corticosteroids
  • Bronchodilators
  • Leukotriene modifiers
  • Immunotherapy
  • Biologics
  • Others
Global Allergic Asthma Therapeutics Market, By Route of Administration:
  • Oral
  • Inhaled
  • Others
Global Allergic Asthma Therapeutics Market, By Region:
  • North America
  • By Country
  • U.S.
  • Canada
  • Latin America
  • By Country
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • By Country
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • By Country
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Country/Region
  • South Africa
  • Central Africa
  • North Africa
Company Profiles
  • Aslan Pharmaceuticals, Pte. Ltd.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Baxalta Incorporated
  • Axikin Pharmaceuticals
  • Chiesi Farmaceutici SpA
  • CSL Limited
  • Circassia Pharmaceuticals Plc
  • Fountain Biopharma Inc.
  • Hydra Biosciences
  • GlaxoSmithKline Plc
  • Infinity Pharmaceuticals
  • Mabtech Limited
  • Kineta
  • Marinomed Biotechnologie Gmb
  • NeoPharm Co.
  • Mycenax Biotech Inc.
  • Panacea Biotec Limited
  • Oxagen Limited
“*” marked represents similar segmentation in other categories in the respective section.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Axikin Pharmaceuticals
  • Chiesi Farmaceutici SpA
  • Fountain Biopharma Inc.
  • Hydra Biosciences
  • Kineta
  • Mycenax Biotech Inc.
1. Research Objectives and Assumptions
  • Research Objectives
  • Assumptions
  • Abbreviations
2. Market Overview
  • Report Description
  • Market Definition and Scope
  • Executive Summary
  • Market Snippet, By Drug Type
  • Market Snippet, By Route of Administration
  • Market Snippet, By Region
  • Opportunity Map
3. Market Dynamics, Regulations, and Trends Analysis
  • Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
  • Impact Analysis
  • Technological Advancements in Allergic Asthma Therapeutics
  • Key Developments
  • Acquisition, Collaborations & Partnerships
  • Epidemiology
  • Pipeline Analysis
  • Patent Expiration
  • Pricing Analysis
4. Global Allergic Asthma Therapeutics Market, Impact of Coronavirus (Covid-19) Pandemic
  • Pre-COVID situation
  • Post-COVID demand
  • Need for Allergic Asthma Therapeutics
  • Recommendations and guidelines by regulatory bodies
5. Global Allergic Asthma Therapeutics Market, By Drug Type, 2016 - 2027, (US$ Million)
  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017 - 2027
  • Segment Trends
  • Bronchodilators
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Corticosteroids
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Biologics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Leukotriene modifiers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Immunotherapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
6. Global Allergic Asthma Therapeutics Market, By Route of Administration, 2016 - 2027, (US$ Million)
  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017 - 2027
  • Segment Trends
  • Oral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Inhaled
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
7. Global Allergic Asthma Therapeutics Market, By Region, 2016 - 2027, (US$ Million)
  • Introduction
  • Market Share Analysis, By Region, 2020 and 2027(%)
  • Y-o-Y Growth Analysis, By Region, 2017 -2027
  • Regional Trends
  • North America
  • Market Size and Forecast, By Drug Type, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Route of Administration, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
  • U.S.
  • Canada
  • Europe
  • Market Size and Forecast, By Drug Type, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Route of Administration, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • Market Size and Forecast, By Drug Type, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Route of Administration, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Market Size and Forecast, By Drug Type, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Route of Administration, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Africa
  • Market Size and Forecast, By Drug Type, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Route of Administration, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Country/Region, 2016 - 2027, (US$ Million)
  • North Africa
  • Central Africa
  • South Africa
  • Middle East
  • Market Size and Forecast, By Drug Type, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Route of Administration, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
  • GCC
  • Israel
  • Rest of Middle East
8. Competitive Landscape
  • Company Profiles
  • Aslan Pharmaceuticals Pte. Ltd.
  • Company Overview
  • Type Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Baxalta Incorporated
  • Company Overview
  • Type Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Axikin Pharmaceuticals
  • Company Overview
  • Type Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Chiesi Farmaceutici SpA
  • Company Overview
  • Type Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • CSL Limited
  • Company Overview
  • Type Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Circassia Pharmaceuticals Plc
  • Company Overview
  • Type Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Fountain Biopharma Inc.
  • Company Overview
  • Type Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Hydra Biosciences
  • Company Overview
  • Type Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • GlaxoSmithKline Plc
  • Company Overview
  • Type Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Infinity Pharmaceuticals
  • Company Overview
  • Type Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Mabtech Limited
  • Company Overview
  • Type Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Kineta
  • Company Overview
  • Type Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Marinomed Biotechnologie GmbH
  • Company Overview
  • Type Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • NeoPharm Co.
  • Company Overview
  • Type Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Mycenax Biotech Inc.
  • Company Overview
  • Type Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Panacea Biotec Limited
  • Company Overview
  • Type Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Oxagen Limited
  • Company Overview
  • Type Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
9. Section
  • References
  • Research Methodology
  • About Us and Sales Contact
Note: Product cover images may vary from those shown
  • Aslan Pharmaceuticals, Pte. Ltd.
  • Baxalta Incorporated
  • Axikin Pharmaceuticals
  • Chiesi Farmaceutici SpA
  • CSL Limited
  • Circassia Pharmaceuticals Plc
  • Fountain Biopharma Inc.
  • Hydra Biosciences
  • GlaxoSmithKline Plc
  • Infinity Pharmaceuticals
  • Mabtech Limited
  • Kineta
  • Marinomed Biotechnologie Gmb
  • NeoPharm Co.
  • Mycenax Biotech Inc.
  • Panacea Biotec Limited
  • Oxagen Limited
Note: Product cover images may vary from those shown
Adroll
adroll